Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2018

View Archived Issues

FDA grants QIDP designation to ACX-362E to treat C. difficile infection

Metastatic breast cancer regression by immunotherapy with TILs enriched for neoantigen reactivity

PTC Therapeutics presents updated preliminary data from FIREFISH

Reata initiates first-in-human study with allosteric RORgammat inhibitor RTA-1701

Preliminary data presented from first-in-human phase I trial on MTL-CEBPA

First-in-human data presented for novel monoclonal anti-IL-6R-alpha antibody BCD-089

HTX-011 receives breakthrough therapy designation and reaches primary endpoint in phase IIb studies

Researchers present primary efficacy data on PRO-140 from CD02 study

MaaT Pharma enters agreement for GvHD microbiome therapy

New dUTPase inhibitors synthesized at CV6 Therapeutics

Bristol-Myers Squibb describes glycogen synthase kinase 3 inhibitors

Dual MetAP 2/DPP-IV inhibitors identified at Lilly

Statins improve venetoclax anticancer activity in hematologic malignancies

FDA grants regenerative medicine advanced therapy designation for VY-AADC

Alpha Biopharma closes series A financing for phase II study of AZD-3759

ACKR3 gene copy number variations linked to pregnancy loss

Ironwood initiates phase III trials of IW-3718 in persistent GERD

Attenuated vaccine candidate shows rapid probiotic-like protection from cholera in animal models

Revance initiates phase III program with RT-002 injectable for cervical dystonia

FDA accepts sBLA for Opdivo plus low-dose Yervoy for first-line NSCLC

Phase II/III trial of NBTXR-3 in soft tissue sarcoma meets primary endpoint

Synairgen reports interim data from phase II trial of SNG-001 in COPD

Takeda acquires control of TiGenix

REACH1 study of ruxolitinib in steroid-refractory acute GvHD meets primary endpoint

FDA accepts IND for lanifibranor in patients with type 2 diabetes and NAFLD

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...